Compare ADUS & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADUS | PBH |
|---|---|---|
| Founded | 1979 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.3B |
| IPO Year | 2009 | 2004 |
| Metric | ADUS | PBH |
|---|---|---|
| Price | $126.22 | $49.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 7 |
| Target Price | ★ $134.08 | $67.80 |
| AVG Volume (30 Days) | 163.0K | ★ 479.6K |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.40 | N/A |
| EPS | ★ 2.85 | 0.61 |
| Revenue | N/A | ★ $975,777,000.00 |
| Revenue This Year | $7.10 | $17.00 |
| Revenue Next Year | $4.81 | $6.06 |
| P/E Ratio | ★ $43.85 | $80.22 |
| Revenue Growth | N/A | ★ 36.77 |
| 52 Week Low | $87.95 | $42.62 |
| 52 Week High | $126.62 | $71.07 |
| Indicator | ADUS | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 74.60 | 56.02 |
| Support Level | $114.18 | $47.61 |
| Resistance Level | N/A | $50.00 |
| Average True Range (ATR) | 2.66 | 1.42 |
| MACD | 0.94 | 0.09 |
| Stochastic Oscillator | 94.92 | 68.52 |
Addus HomeCare Corp is engaged in the provision of in-home care services. The Company has three reportable segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, mainly to the elderly, chronically ill, and disabled individuals. The Hospice segment provides physical, emotional, and spiritual care for terminally ill patients and their families. The Home Health segment provides medical services to individuals requiring care during illness or recovery. It generates the majority of its revenue from the Personal Care segment.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.